Idinvest makes 7.6x return with biotech exit

Prosensa, a Dutch company whose products treat genetic disorders, is being taken private for up to $840m

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this